Proactive Investors - Run By Investors For Investors

MedMen completes acquisition to open first store in Arizona

The cannabis company gained control of Monarch, a dispensary, cultivator and processor of medical cannabis
Marijuana with a stethoscope
Arizona is estimated to have around 180,000 medical marijuana patients

MedMen Enterprises Inc (CSE:MMEN) (OTCQX:MMNFF) completed its acquisition of Omaha Management Services LLC, one of the top medical marijuana operators in Arizona.

MedMen gains control of Monarch, an Arizona-based dispensary, cultivator and processor of medical cannabis.

READ: MedMen’s latest acquisition to expand its presence in the Arizona cannabis market

The cannabis company financed the deal with 80% in stock and 20% in cash.

Monarch, one of Scottsdale’s first dispensaries, opened under MedMen management on Monday and will be rebranded as a MedMen store.

“As we look to operationalize the acquisitions we have made in recent months, our team has focused on timely and seamless transitions,” said CEO Adam Bierman in the company’s press release.

MedMen also operates a 20,000 square foot cultivation and manufacturing facility in Mesa, which distributes branded products to over 60 dispensaries in the state.

The company’s agreement with WhiteStar Solutions LLC grants exclusive co-manufacturing and licensing agreements for other popular brands in Arizona including Kiva, Mirth Provisions, HUXTON and Old Pal.

MedMen views Arizona as one of the largest medical marijuana markets in the US, with more than 180,000 patients, especially with a legalization ballot expected to be introduced again in 2020 after a failed attempt in 2016.

Shares of MedMen slipped more than 5% to C$4.16 in Wednesday morning trading.

 

Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full MMEN profile View Profile

MedMen Enterprises Inc Timeline

Newswire
December 06 2018
Article
October 24 2018

Related Articles

medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
cannabis plan in sun
February 21 2019
The cannabis company will manufacture, infuse and package branded recreational and wellness products
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use